Roadblocks Confronting Widespread Dissemination and Deployment of Organs on Chips
Overview
Affiliations
Organ on Chip platforms hold significant promise as alternatives to animal models or traditional cell cultures, both of which poorly recapitulate human pathophysiology and human level responses. Within the last 15 years, we have witnessed seminal scientific developments from academic laboratories, a flurry of startups and investments, and a genuine interest from pharmaceutical industry as well as regulatory authorities to translate these platforms. This Perspective identifies several fundamental design and process features that may act as roadblocks that prevent widespread dissemination and deployment of these systems, and provides a roadmap to help position this technology in mainstream drug discovery.
Human-based complex models: their promise and potential for rare disease therapeutics.
Parvatam S, Pistollato F, Marshall L, Furtmann F, Jahagirdar D, Chakraborty Choudhury M Front Cell Dev Biol. 2025; 13:1526306.
PMID: 39931243 PMC: 11807990. DOI: 10.3389/fcell.2025.1526306.
Advanced In Vitro Models for Preclinical Drug Safety: Recent Progress and Prospects.
Nair D, Weiskirchen R Curr Issues Mol Biol. 2025; 47(1).
PMID: 39852122 PMC: 11763796. DOI: 10.3390/cimb47010007.
Drabbe E, Pelaez D, Agarwal A Lab Chip. 2024; .
PMID: 39659219 PMC: 11632457. DOI: 10.1039/d4lc00771a.